{"": [113, 1858, 0], "Introduction": [1859, 9231, 0], "Cell culture": [9255, 10617, 0], "Virus neutralization assay": [10618, 12288, 0], "ELISA": [12289, 13740, 0], "Anti-SARS-CoV-2 antibody/serology assays": [13741, 15043, 0], "CCP recipients and clinical parameters": [15044, 16536, 0], "Statistical analysis": [16537, 16874, 0], "Data sharing statement": [16875, 16955, 0], "Methods and materials": [9232, 16955, 1], "Variation of neutralizing titer in the presence of Fc\u03b1R or Fc\u03b3RIIA": [22910, 24234, 0], "Correlation of anti-S IgG, IgA, and IgM with IC50 data": [24235, 25795, 0], "Results": [16956, 25795, 1], "Discussion": [25796, 31172, 0], "Supporting information": [31173, 31288, 0]}